Clinical Development of Inhibitors of the Insulin-like Growth Factor Receptor in Oncology

E-ISSN： 1873-5592|10|10|923-936

ISSN： 1389-4501

Source： Current Drug Targets, Vol.10, Iss.10, 2009-10, pp. : 923-936

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The potential role of insulin-like growth factor receptor inhibitors in the treatment of advanced non-small cell lung cancer

By Gridelli Cesare Rossi Antonio Bareschino Maria Anna Schettino Clorinda Sacco Paola Claudia Maione Paolo

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 5, 2010-05 ,pp. : 631-639

Informa Healthcare

Access to resources Recommend Favorite

Insulin-like Growth Factor-1 Receptor (IGF-1R) Kinase Inhibitors in Cancer Therapy: Advances and Perspectives

Current Pharmaceutical Design, Vol. 18, Iss. 20, 2012-07 ,pp. : 2901-2913

Bentham Science Publishers

Access to resources Recommend Favorite

The insulin-like growth factor-I receptor as a target for cancer therapy

By Baserga Renato

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 753-768

Informa Healthcare

Access to resources Recommend Favorite

Insulin-like growth factor-I receptor – a potential therapeutic target in medulloblastomas

By Reiss Krzysztof

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 5, 2002-10 ,pp. : 539-544

Informa Healthcare

Access to resources Recommend Favorite

Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer

By Yuen John SP Macaulay Valentine M

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 5, 2008-05 ,pp. : 589-603

Informa Healthcare

Access to resources Recommend Favorite